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A single strain of Mycobacterium abscessus subsp. bolletii, characterised by a particular rpoB sequevar and 
two highly related pulsed field gel electrophoresis patterns has been responsible for a nationwide outbreak of sur-
gical infections in Brazil since 2004. In this study, we developed molecular tests based on polymerase chain reac-
tion restriction-enzyme analysis (PRA) and sequencing for the rapid identification of this strain. Sequences of 15 
DNA regions conserved in mycobacteria were retrieved from GenBank or sequenced and analysed in silico. Single 
nucleotide polymorphisms specific to the epidemic strain and located in enzyme recognition sites were detected in 
rpoB, the 3’ region of the 16S rDNA and gyrB. The three tests that were developed, i.e., PRA-rpoB, PRA-16S and 
gyrB sequence analysis, showed 100%, 100% and 92.31% sensitivity and 93.06%, 90.28% and 100% specificity, 
respectively, for the discrimination of the surgical strain from other M. abscessus subsp. bolletii isolates, includ-
ing 116 isolates from 95 patients, one environmental isolate and two type strains. The results of the three tests were 
stable, as shown by results obtained for different isolates from the same patient. In conclusion, due to the clinical and 
epidemiological importance of this strain, these tests could be implemented in reference laboratories for the rapid 
preliminary diagnosis and epidemiological surveillance of this epidemic strain. 
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More than 2,000 cases of patients showing surgical-
site infections caused by rapidly growing mycobacteria 
(RGM) were reported to the Brazilian National Health 
Surveillance Agency (ANVISA) between 2003-2008. 
This was a sudden increase relative to previous years with 
only 13 cases reported between 2000-2003 (ANVISA 
2009). Most of the infections were related to laparoscopic 
or arthroscopic surgeries and were caused by RGM with 
a Mycobacterium abscessus type 2 polymerase chain re-
action (PCR) restriction-enzyme analysis (PRA)-hsp65 
pattern (BstE II: 235 and 210 bp; Hae III: 200, 70, 60 and 
50 bp) (Devallois et al. 1997). The identification of these 
isolates was confirmed by rpoB sequencing (Adékambi et 
al. 2003). All of the obtained sequences were highly simi-
lar to the rpoB sequence of Mycobacterium massiliense 
CCUG 48898 (GenBank accession AY593981.2) and had 
two base substitutions (GenBank accession EU117207) 
(Leão et al. 2010). A total of 152 isolates obtained from 
surgical patients in different states belonged to a single 
strain and showed two closely related pulsed field gel 
electrophoresis (PFGE) patterns with a one-band differ-
ence when using either DraI or AseI restriction enzymes 
(Cardoso et al. 2008, Viana-Niero et al. 2008, Duarte 
et al. 2009, Leão et al. 2010). This strain was classified 
as M. abscessus subsp. bolletii according to the revised 
taxonomic status of the members of the Mycobacterium 
chelonae-M. abscessus group (Leão et al. 2009, 2011). 
One representative isolate from this strain was deposited 
in the collection of the National Institute for Quality and 
Health Control (INCQS), Rio de Janeiro (RJ), Brazil, un-
der the accession INCQS 00594.
The epidemiological importance of this strain, which 
is herein referred to as the epidemic strain, is attributed 
to the extensive geographic and temporal occurrence of 
the epidemic of surgical-site infections (ANVISA 2011). 
Additionally, this strain was isolated from sputum, bron-
choalveolar lavage fluid (BAL) and urine from patients 
unrelated to the outbreak (Matsumoto et al. 2011). The 
reports of RGM infections related to surgical procedures 
diminished significantly after 2008, although in 2010 
additional surgical patients infected by the same strain 
were reported in the states of Amazonas (AM) and Rio 
Grande do Sul (RS), demonstrating that these infections 
may become endemic to Brazil. 
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Currently, the identification of this particular strain 
is based on rpoB sequencing and typing by PFGE. We 
have recently demonstrated that PFGE is a valid typing 
method for M. abscessus subsp. abscessus (Sampaio et 
al. 2006) and M. abscessus subsp. bolletii (Matsumoto et 
al. 2011). Sequencing and PFGE are not available in most 
public laboratories in Brazil and the epidemiological sur-
veillance of this outbreak has suffered from the lack of a 
simple and rapid test to screen M. abscessus subsp. bol-
letii isolates, particularly when these isolates are derived 
from patients submitted to invasive procedures, such as 
laparoscopic, arthroscopic and plastic surgeries.
The objective of this study was to develop rapid tests 
for the specific identification of the epidemic strain 
among RGM isolates showing the M. abscessus type 2 
PRA-hsp65 pattern.
SUBJECTS, MATERIALS AND METHODS
Mycobacterial isolates - A total of 116 mycobacterial 
isolates showing the M. abscessus type 2 PRA-hsp65 pat-
tern were included in this study. Isolates were classified 
as belonging to the epidemic strain when they showed one 
of the two PFGE patterns that were previously defined 
as being characteristic of this strain (Leão et al. 2010). 
Isolates showing highly similar PFGE patterns (differing 
from the epidemic strain patterns by up to three bands) 
corresponded to subtypes of the epidemic strain, accord-
ing to van Belkum et al. (2007), and were categorised as 
genetically related (Matsumoto et al. 2011).
The type strains M. bolletii CCUG 50184 and M. 
massiliense CCUG 48898, both of which were reclassi-
fied as M. abscessus subsp. bolletii by Leão et al. (2011), 
and 55 clinical isolates from our collection were used 
in evaluation phases Ia and Ib (described in the Results 
section) (Table I). Only one isolate per patient was in-
cluded. These isolates had been previously characterised 
by rpoB gene sequencing, PFGE-DraI and PFGE-AseI 
(Viana-Niero et al. 2008, da Costa et al. 2009, Duarte et 
al. 2009, Leão et al. 2010, Matsumoto et al. 2011).
Twenty coded isolates from 15 patients from the In-
stitute of Microbiology Professor Paulo de Góes (Federal 
University of Rio de Janeiro) were sent to our laboratory 
(Mycobacteria Laboratory, Federal University of São 
Paulo) and used for the evaluation of the PRA-rpoB in 
evaluation phase IIa (Fig. 1).
Thirty-nine isolates from 26 patients, received between 
January 2009-May 2010 at the National Reference Labora-
tory Professor Hélio Fraga (CRPHF), RJ, were analysed 
locally by PRA-rpoB in evaluation phase IIb (Fig. 2).
The 59 isolates used in phases IIa and IIb were later 
characterised by gyrB and rpoB sequencing, PRA-16S 
and PFGE-DraI.
PFGE typing - PFGE typing was performed as de-
scribed in previous publications from our group (Leão 
et al. 2010, Matsumoto et al. 2011). PFGE patterns were 
analysed using the BioNumerics v. 5.1 program (Applied 
Maths, Sint-Martens-Laten, Belgium). 
PCR and DNA sequencing - The primers used for the 
PCR amplification and sequencing of rpoB, the 3’ region 
of the 16S rDNA and gyrB genes are listed in Table II. The 
rpoB amplification was performed using primers MycoF 
and MycoR, as described by Adékambi et al. (2003).  Two 
primers described in previous publications (Adékambi & 
Drancourt 2004, Gomila et al. 2007) were used for the 
amplification and sequencing of the 3’ region of the 16S 
rDNA. The gyrB amplification primers were designed 
based on the sequence of the M. abscessus ATCC 19977 
genome (GenBank accession NC_010397).
PCR products were purified by gel filtration (HiYield 
Gel/PCR DNA Extraction kit - RBC Biosciences Corp, 
Taipei, Taiwan). Dideoxy sequencing was performed us-
ing a BigDye® Terminator v3.1 Cycle Sequencing Kit 
(Applied Biosystems, Foster City, CA, USA) and an ABI 
PRISM 3100 DNA Analyzer (Applied Biosystems) ac-
cording to the manufacturer’s instructions. 
The rpoB sequences from INCQS 00594, the M. 
massiliense and M. bolletti type strains, as well as the 16S 
rDNA sequences from M. massiliense and M. bolletii, 
were obtained from GenBank (EU117207, AY593981.2, 
AY859692, AY593980 and AY859681).
DNA sequence analysis - Sequences were aligned 
using the CLUSTALW Multiple Alignment program 
(Thompson et al. 1994) included in the BioEdit v. 7.0.5.3 
package (Hall 1999). Single nucleotide polymorphisms 
(SNPs) present exclusively in the INCQS 00594 sequenc-
es were identified. For the development of the PRA tests, 
SNPs located in enzyme recognition sites were identi-
fied using the NEBcutter v.2.0 (Vincze et al. 2003). 
All of the nucleotide positions described in the text 
correspond to positions in the M. abscessus ATCC 19977 
genome (GenBank accession NC_010397).
PRA-rpoB - For the PRA-rpoB determinations, the 
primers MycoF (Adékambi et al. 2003) and MycoR2 
(Table II) were used to amplify a 221 bp fragment of the 
rpoB gene. The 15 µL reactions were composed of the 
following reagents: 1.5 µL of 10X Buffer (150 mM Tris-
HCl, pH 8.75, 500 mM KCl, 1% Triton X-100 and 20 mM 
of MgCl2), 140 µM of each dNTP, 0.4 µM of each primer, 
0.3 U of Taq DNA Polymerase (RBC Biosciences Corp, 
Taipei, Taiwan) and 2 µL of DNA. The PCR was per-
formed using the following conditions: an initial dena-
turation step at 95ºC for 3 min, 35 cycles of 95ºC for 30 
sec, 65ºC for 30 sec and 72ºC for 1 min and a final exten-
sion at 72ºC for 5 min. The digestion of 10 µL aliquots 
of the PCR product using DpnII (New England Biolabs, 
Ipswich, MA, USA) was carried out in a final volume of 
20 µL according to the manufacturer’s instructions.
PRA-16S - For the PRA-16S determinations, the prim-
ers 800F (Adékambi & Drancourt 2004) and 16R1492 
(Gomila et al. 2007) were used to amplify a 733 bp frag-
ment. The same reagents, volumes and amplification con-
ditions described above were used in the 16S rDNA PCR 
with the exception of changes in the MgCl2 concentration 
(1.5 mM final concentration) and the annealing tempera-
ture (60ºC). A 10 µL aliquot of the PCR product was di-
gested with XbaI (Promega, Madison, WI, USA) in a 20 µL 
reaction according to the manufacturer’s instructions.
gyrB sequence analysis - For the gyrB sequence anal-
ysis, a 524 bp fragment was amplified using the primers 
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TABLE I
Mycobacterium abscessus type 2 isolates used in phases Ia, Ib, IIa and IIb and results obtained  
with polymerase chain reaction restriction-enzyme analysis (PRA)-rpoB, PRA-16S and gyrB sequence analysis
Phase Isolatea Year of isolation State PRA-rpoB PRA-16S gyrB analysis
Ia CCUG 48898 - - -
CCUG 50184 - - -
INCQS 00594b,c 2005 PA + + +
B67d 2004 PA - - -
IAL 002e 2005 CE - - -
IAL 014e 2006 SP - - -
IAL 028e 2008 SP - - -
P7e 2006 PA - - -
P13e 2006 PA - - -
 P53e 2007 PA - - -
Ib B52b ,c 2004 PA + + +
CRM 0019b ,c 2006 RJ + + +
CRM 0184b ,c 2006 RJ + + +
RS 700345b ,c 2007 RS + + +
307597b ,c 2007 ES + + +
IAL 040b ,c 2008 PR + + +
IAL 041b ,c 2008 PR + + +
IAL 042b ,c 2008 SP + + +
IAL 043b ,c 2008 SP + + +
CRM 270e,f 2007 RJ + + -
CRM 273e,f 2007 RJ + + -
IAL 020c,e 2006 SP + + +
IAL 034c,g 2006 SP + + +
IAL 036c,h 2006 CE + + -
P10c,e 2005 PA + + -
IAL 001e 2005 CE - - -
IAL 003e 2005 CE - + -
IAL 004e 2006 CE - - -
IAL 005e 2006 CE - - -
IAL 006e 2006 CE - - -
IAL 007e 2008 DF - - -
IAL 008e 2007 MS - - -
IAL 009e 2006 MS - - -
IAL 010e 2007 MT - - -
IAL 011e 2007 PI - - -
IAL 012e 2005 SP - - -
IAL 013e 2005 SP - - -
IAL 015e 2006 SP - - -
IAL 016e 2007 SP - - -
IAL 017e 2007 SP - - -
IAL 018e 2007 SP - - -
IAL 019e 2007 SP - - -
IAL 021e 2006 SP - - -
IAL 024e 2005 SP - - -
IAL 029e 2005 SP - - -
IAL 035i 2007 SP - - -
IAL 037j 2006 SP - - -
MG3-6k 2005 ES - - -
P3e 2004 PA - - -
P4e 2007 PA - - -
P5e 2005 PA - - -
P6e 2004 PA - - -
P8e 2006 PA - - -
P14e 2004 PA - + -
P51e 2002 PA - - -
P52e 2003 PA - - -
 P54e 2006 PA - - -
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GYRB7 and GYRB8 (Table II) in a 25 µL reaction us-
ing the same reagents and concentrations described for 
PCR-rpoB but with a 60ºC annealing temperature. The 
primer GYRB7 was used for sequencing.
Nucleotide sequence accessions - The sequences ob-
tained from this work were deposited in GenBank under 
the following accessions: GU131159-GU131161, GU143881, 
GU143882, GU143885-GU143887, GU143888.2, GU143891, 
JQ582469-JQ582622 and JQ678790-JQ678815.
RESULTS
The development and evaluation of the tests for the 
rapid detection of the epidemic strain were performed in 
four consecutive phases (Ia, Ib, IIa and IIb) (Table I).
In phase Ia, the sequences of three genes (rpoB, the 
3’ region of the 16S rDNA and gyrB) were analysed. 
The INCQS 00594 sequences were aligned to the cor-
responding sequences from M. bolletii CCUG 50184, 
M. massiliense CCUG 48898 and seven randomly se-
Phase Isolatea Year of isolation State PRA-rpoB PRA-16S gyrB analysis
IIa CRM 311b,c 2008 RJ + + +
CRM 312b,c 2008 RJ + + +
CRM 313b ,c 2008 RJ + + +
CRM 353b ,c 2008 PR + + +
CRM 375e, CRM 378e, CRM 405e 2008 RJ - - -
CRM 409e, CRM 416e 2008 RJ - - -
CRM 473e, CRM 639e 2009 RJ - - -
CRM 512e, CRM 640e 2009 RJ - - -
CRM 552c,g 2009 RJ + + +
CRM 572b ,c 2009 RJ + + +
CRM 573e 2009 RJ - + -
CRM 575b ,c 2009 RJ + + +
CRM 619b ,c 2009 PR + + +
CRM 622c,g 2009 RJ + + +
 CRM 642e 2009 RJ - - -
IIb CRPHF 3451e, CRPHF 3498e, CRPHF 4163e, 
CRPHF 4402e, CRPHF 4406e, CRPHF 4407e
2009 RJ - - -
CRPHF 3452e, CRPHF 4343e 2009 RJ - - -
CRPHF 3464b, c 2009 RJ + + +
CRPHF 3541e, CRPHF 4811e 2009 PE - - -
CRPHF 3633e 2009 PE - - -
CRPHF 3634g 2009 PE - - -
CRPHF 3761c,g 2009 AL + + +
CRPHF 3850e 2009 PE - - -
CRPHF 3851b 2009 PE - - -
CRPHF 3882e 2009 RJ - - -
CRPHF 3918g 2009 RS - - -
CRPHF 3932g 2009 RS - - -
CRPHF 3941e 2009 RS - - -
CRPHF 4013e 2009 MT - - -
CRPHF 4168e 2009 RJ - - -
CRPHF 4301e 2009 MA - - -
CRPHF 4636b ,c 2009 RJ + + +
CRPHF 4760e 2009 CE + - -
CRPHF 4817b 2009 PE - - -
CRPHF 5813e, CRPHF 5814e,  
CRPHF 6107i, CRPHF 6108i
2009 GO - - -
CRPHF 6026e,f, CRPHF 6027e,f 2009 RR + + -
CRPHF 6244e 2010 MS - - -
CRPHF 6263d 2010 RO - - -
CRPHF 6492e,f, CRPHF 6493e,f 2010 RS + + -
CRPHF 6619e, CRPHF 6620e 2010 RO - - -
 CRPHF 6979b 2010 MG - - -
a: isolates obtained from the same patient were grouped; b: surgical isolate; c: isolates that belong to the epidemic strain; d: injec-
tion site abscess; e: sputum; f: isolates genetically related to the epidemic strain; g: bronchoalveolar lavage; h: urine; i: blood; j: 
parotid nodule; k: sewage; AL: Alagoas; CE: Ceará; DF: Federal District; ES: Espírito Santo; GO: Goiás; MA: Maranhão; MG: 
Minas Gerais; MS: Mato Grosso do Sul; MT: Mato Grosso; PA: Pará; PE: Pernambuco; PI: Piauí; PR: Paraná; RJ: Rio de Janeiro; 
RO: Rondônia; RR: Roraima; RS: Rio Grande do Sul; SP: São Paulo; +: epidemic strain by the test; -: different strain by the test.
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lected isolates that did not belong to the epidemic strain 
(B67, IAL 002, IAL 014, IAL 028, P7, P13 and P53). 
The seven non-epidemic strains were not isolated from 
surgical-site infections and their rpoB sequences and 
PFGE patterns were different from those of the epidem-
ic strain. All of the isolates showed the M. abscessus 
type 2 PRA-hsp65 pattern.
The following SNPs that occur only in INCQS 00594 
and are located in restriction enzyme recognition sites 
were identified: an A/G SNP at position 3,916,702 in 
rpoB, located in a DpnII restriction site (AATC in the ep-
idemic strain and GATC in isolates from other strains), a 
T/C SNP at position 1,463,374 in the 16S rDNA, located 
in a XbaI recognition site (TCTAGA in isolates belong-
ing to the epidemic strain and CCTAGA in isolates that 
do not belong to the epidemic strain), and an A/C SNP 
at position 8,148 in gyrB, located in a TauI recognition 
site (GCSGC, where S indicates C or G; GAGGC in the 
epidemic strain; GCGGC in non-epidemic strain). 
Three tests were developed in phase Ib, two tests are 
based on PRA (PRA-rpoB and PRA-16S) and one test is 
based on gyrB sequencing. 
The 752 bp rpoB fragment described by Adékambi et 
al. (2003) contains multiple DpnII recognition sites and 
a new primer, MycoR2 (Table II), was designed for the 
amplification of a 221 bp fragment that contains only the 
DpnII site of interest. This DpnII restriction site is absent 
in the epidemic strain due to an A/G substitution and the 
corresponding amplicon was not cut with this enzyme. 
In contrast, this DpnII restriction site was present in the 
analysed isolates that are not related to the epidemic strain 
and digestion of the PCR products from these isolates with 
DpnII generated two fragments of 168 bp and 53 bp.
For the PRA-16S determination, primers 800F and 
16R1492 (Table II) were used to amplify a 733 bp frag-
ment of the 16S rDNA gene and the amplicon was digest-
ed with XbaI. The XbaI restriction site was present ex-
clusively in the strain INCQS 00594 and two fragments 
of 503 bp and 230 bp were produced by the PRA-16S 
test. The 16S amplicons of the strains unrelated to the 
epidemic strain were not digested.
Additional TauI sites in gyrB are present 20 bp down-
stream from the SNP of interest, thereby complicating 
the design of a PRA test. The relatively small size differ-
ence between the digested and non-digested fragments 
would not be detectable using agarose gels. As an alter-
native approach, the outbreak strain was discriminated 
using sequence analysis.
Of the 47 isolates used in the three tests in phase Ib, 
13 belonged to the epidemic strain, nine were retrieved 
from surgical-site infections (307597, B52, CRM 0019, 
CRM 0184, IAL 040, IAL 041, IAL 042, IAL 043 and 
RS 700345) and four were isolated from other speci-
mens (IAL 020 and P10 from sputum, IAL 034 from 
BAL and IAL 036 from urine). Two of the sputum iso-
lates (CRM 270 and CRM 273) showed PFGE patterns 
that differed in two bands when compared to the pat-
terns of the epidemic strain isolates and were thus con-
sidered genetically related to the epidemic strain (Mat-
sumoto et al. 2011). The nine isolates from surgical-site 
infections and isolates IAL 020 and IAL 034 from the 
other specimens were correctly identified by the three 
Fig. 1: pulsed field gel electrophoresis (PFGE)-DraI patterns of isolates from Federal University of Rio de Janeiro used in evaluation phase IIa. 
Nine isolates belonging to the epidemic strain are boxed. BAL: bronchoalveolar lavage. Asterisks mean Matsumoto et al. (2011).
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tests as belonging to the epidemic strain. Two isolates 
that are genetically related to the epidemic strain (CRM 
270 and CRM 273) tested positive by PRA-rpoB and 
PRA-16S, but did not show the SNP that is charac-
teristic of the epidemic strain according to gyrB se-
quence analysis. Two isolates from strains other than 
the epidemic strain (IAL 003 and P14) were identified 
by PRA-16S as belonging to the epidemic strain (i.e., 
false positives). False negative results from the gyrB 
sequence analysis were observed for isolates IAL 036 
and P10, which belong to the epidemic strain (Table I). 
PRA-rpoB was selected for the evaluation phases IIa 
and IIb. Additionally, PRA-16S and gyrB sequence 
analyses were performed to complement the previously 
obtained results.
A total of 20 coded isolates from 15 patients were 
used in a blind evaluation of the PRA-rpoB test (phase 
IIa). Nine isolates showed positive results and were re-
sistant to digestion with DpnII, which is characteristic 
of the epidemic strain. Seven of these isolates (CRM 311, 
CRM 312, CRM 313, CRM 353, CRM 572, CRM 575 
and CRM 619) were obtained from surgical-site infec-
tions and two were isolated from BAL (CRM 552 and 
CRM 622). Eleven isolates, none of which were from 
surgical patients, tested negative (i.e., the rpoB amplicon 
was cut with DpnII). The results obtained from the gyrB 
sequence analysis were consistent with the PRA-rpoB 
results. The PRA-16S test identified an additional isolate 
from a sputum sample (CRM 573) as belonging to the 
epidemic strain. The characterisation of these isolates by 
PFGE confirmed that the nine isolates that tested posi-
tive by the three developed tests belonged to the epidem-
ic strain and that CRM 573 was a false positive result of 
PRA-16S (Fig. 1, Table I).
In the final evaluation (phase IIb), the PRA-rpoB de-
terminations were performed in a different laboratory. 
Fig. 2: pulsed field gel electrophoresis (PFGE)-DraI patterns of isolates from National Reference Laboratory Professor Hélio Fraga (CR-
PHF), state of Rio de Janeiro, used in evaluation phase IIb. A: isolates belonging to the epidemic strain; B: genetically related isolates; 
BAL: bronchoalveolar lavage.
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The PRA-rpoB protocol and primers were sent to the 
laboratory at CRPHF and 39 isolates from 26 patients 
with the M. abscessus type 2 PRA-hsp65 pattern were 
tested at CRPHF. Eight isolates from six patients tested 
positive by PRA-rpoB. Of these eight isolates, only two 
isolates (CRPHF 3464 and CRPHF 4636) were recov-
ered from patients that had undergone surgical proce-
dures. Five isolates (CRPHF 4760, CRPHF 6026, CR-
PHF 6027, CRPHF 6492 and CRPHF 6493) from three 
patients were obtained from sputum samples and one 
isolate (CRPHF 3761) was obtained from BAL. The re- 
maining 31 isolates tested negative for the epidemic 
strain (Table I). These results were compared to the 
results obtained from the PRA-16S and gyrB sequence 
analyses. All but one (CRPHF 4760) of the PRA-16S re-
sults were consistent with the results obtained by PRA-
rpoB. The gyrB SNP that is characteristic of the epidem-
ic strain was detected only in the two surgical isolates 
and in the BAL isolate that tested positive by PRA-rpoB 
and PRA-16S. The comparison of these results with the 
results of the rpoB sequencing and PFGE-DraI deter-
minations showed that the two surgery isolates and the 
BAL isolate that tested positive according to all three 
of the developed tests (CRPHF 3464, CRPHF 3761 and 
CRPHF 4636) belonged to the epidemic strain and four 
out of five of the sputum isolates that tested positive by 
PRA-rpoB and PRA-16S (CRPHF 6026, CRPHF 6027, 
CRPHF 6492 and CRPHF 6493) were genetically relat-
ed to the epidemic strain (Fig. 2). The fifth sputum iso-
late (CRPHF 4760) was not related to the epidemic strain 
and therefore was a false positive PRA-rpoB result. All 
of the remaining isolates, including three isolates from 
surgical-site infections (CRPHF 3851, CRPHF 4817 and 
CRPHF 6979), tested negative according to the three 
developed tests and belonged to strains other than the 
epidemic strain (Fig. 2, Table I).
Of the 116 isolates included in this study, 95 isolates 
corresponded to one isolate per patient, one environ-
mental isolate and the M. bolletii and M. massiliense 
type strains. Of these 98 isolates, 26 belonged to the epi-
demic strain and 72 belonged to other strains (including 
the isolates that are genetically related to the epidemic 
strain). The PRA-rpoB test showed 100% (26/26) sen-
sitivity, i.e., all isolates belonging to the epidemic strain 
were correctly differentiated. The specificity of this test 
was 93.06% (67/72) due to five false positive results. 
The respective sensitivity values for the PRA-16S and 
gyrB sequence analyses were 100% (26/26) and 92.31% 
(24/26) and the specificity values were 90.28% (65/72) 
and 100% (72/72), respectively (Table III).
TABLE II
Primers used for polymerase chain reaction and sequencing
Gene Primer Sequence 5’-3’
Temperature 
(°C) Reference
rpoB MycoF GGCAAGGTCACCCCGAAGGG 68 Adékambi et al. (2003)
MycoR AGCGGCTGCTGGGTGATCATC 68
MycoR2 CGCTTCTGCGCCACGTACA 62 This paper
16S rDNA 16R1492 TACGGCTACCTTGTTACGACTTa 64 Gomila et al. (2007)
800F ATTAGATACCCTGGTAG 48 Adékambi and Drancourt (2004)
gyrB GYRB1 AGAAGAAGAGTGCCAAGAGCG 64 This paper
GYRB2 CTCATCGGTGAGCTTGATGGT 64
GYRB3 GACCAAGAAGACGGGTACCAC 66
GYRB4 GCTTGGTCTTGGTCTGGCCTT 66
GYRB5 GCCAAGGAGAAGAAGCTCCTC 66
GYRB6 CCATCAACACGATCTTGTGGT 62
GYRB7 GGGTTTTGAAGAACACCGAAG 62
GYRB8 GTCCTTGGCGTTTCGGGTGAT 66
a: primer was modified according to the sequence of 16S rDNA in Mycobacterium abscessus ATCC 19977 (GenBank accession 
NC 010397).
TABLE III
Sensitivity and specificity of polymerase chain reaction  
restriction-enzyme analysis (PRA)-rpoB, PRA-16S  
and gyrB analysis of 98 isolates
Tests
PFGE
Sensitivity 
(%)
Specificity 
(%)P N
PRA-rpoB P 26 5 100
-
93.06
-N 0 67
PRA-16S P 26 7 100
-
90.28
-N 0 65
gyrB analysis P 24 0 92.31
-
100
-N 2 72
pulsed field gel electrophoresis (PFGE) was considered the 
gold standard method to discriminate the epidemic strain. N: 
different strain; P: epidemic strain. 
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DISCUSSION
In this study, we developed three tests for the rapid 
discrimination of the epidemic strain among isolates 
previously identified as M. abscessus type 2 according 
to PRA-hsp65 assays.
Initially, the sequences of 15 DNA different regions 
that are conserved in mycobacteria were studied: hsp65, 
rpoB, gyrA, gyrB, the 5’ and 3’ regions of the 16S rDNA, 
23S rDNA, the 16S-23S internal transcribed sequence 
and genes previously used in multilocus sequence analy-
sis (Macheras et al. 2011), argH, cya, glpK, gnd, pgm, pta 
and purH (data not shown). The sequences of these genes 
from M. massiliense and M. bolletii were retrieved from 
GenBank and aligned to the corresponding sequences 
of INCQS 00594. Additionally, certain isolates included 
in phases Ia and Ib were sequenced. SNPs and enzyme 
restriction sites specific to the epidemic strain were 
identified in silico after sequence alignment. This paper 
describes the analysis of three DNA regions, rpoB, the 3’ 
region of 16S rDNA and gyrB, that contained SNPs that 
were exclusive to the epidemic strain and were located 
in enzyme recognition sites. The other studied regions, 
isolates, accessions and primers are provided in the 
supplementary data. The in silico analysis of glpK and 
pta showed that these genes could represent additional 
targets for the differentiation of the epidemic strain, al-
though they were not used in further studies.
An A/G SNP at nucleotide position 3,916,702 corre-
sponds to the first base of the 857th amino acid (Leu) of 
rpoB and is a synonymous mutation. This SNP is one 
of two SNPs found in the rpoB sequence from INCQS 
00594 (GenBank accession EU117207) that define the 
epidemic strain sequevar. An A/C SNP at nucleotide po-
sition 8,148 corresponds to the first base of the 634th 
gyrB codon (Arg) and is also a synonymous mutation. 
The T/C SNP at nucleotide position 1,463,374 detected 
in the 16S rDNA gene does not occur within hypervari-
able region A or B, which are important for the discrimi-
nation of mycobacterial species (Tortoli 2003).
Of the 22 isolates obtained from surgical patients in 
this study, 19 epidemic strains and three non-epidemic 
strains (CRPHF 3851, CRPHF 4817 and CRPHF 6979) 
were correctly identified by the three methods. 
Thirteen isolates from 11 patients (CRM 270, CRM 
273, CRM 552, CRM 622, CRPHF 3761, CRPHF 6026, 
CRPHF 6027, CRPHF 6492, CRPHF 6493, IAL 020, 
IAL 034, IAL 036 and P10) were identified as belonging 
to the epidemic strain or genetically related according to 
the PFGE results, although these isolates were obtained 
from patients that were not submitted to surgical proce-
dures. Interestingly, all of the genetically related isolates 
(CRM 270, CRM 273, CRPHF 6026, CRPHF 6027, CR-
PHF 6492 and CRPHF 6493) had rpoB sequences that 
were 100% similar to that of the epidemic strain INCQS 
00594. In addition, all of these genetically related iso-
lates were obtained from sputum, thereby indicating that 
a strain that is closely related to the epidemic strain can 
cause pulmonary disease. The 13 non-surgical isolates 
tested positive by PRA-rpoB and PRA-16S, although 
8/13 (61.54%) did not display the gyrB SNP that is char-
acteristic of the epidemic strain.
During the development and evaluation of the PRA-
rpoB test, new surgical-site infections occurred in 
Manaus (AM) and Carazinho (RS) in 2010. Six isolates 
from AM and eight from RS were screened using the 
PRA-rpoB test and were identified as belonging to the 
epidemic strain. These results were corroborated by rpoB 
sequencing and PFGE analyses (data not shown). There-
fore, PRA-rpoB proved useful for the rapid preliminary 
screening of the epidemic strain in field situations.
Using one isolate per patient (98 isolates, including 1 
environmental isolate and the 2 type strains), we observed 
discordant results at frequencies of 5.10% (5/98), 7.14% 
(7/98) and 2.04% (2/98) for the PRA-rpoB, PRA-16S and 
gyrB sequence analyses, respectively. The 100% sensitiv-
ity of the PRA-rpoB test was anticipated because it uses 
one of the two SNPs that are characteristic of the epidemic 
strain rpoB sequevar. The sensitivity of the gyrB sequence 
analysis (92.31%) was lower than the sensitivity values of 
the other two tests (100% each), although no false positive 
results were obtained in the gyrB test and the specificity 
(100%) was higher than those of the PRA-rpoB and PRA-
16S tests. It is important to note that the PRA-rpoB and 
the PRA-16S tests, but not the gyrB sequence analysis, 
identified the genetically related isolates (6 isolates from 
4 patients) as belonging to the outbreak strain. Therefore, 
the gyrB sequence analysis appears to be more specific to 
the identification of the outbreak strain, whereas the other 
two tests can also be used to identify genetically related 
isolates. The choice of specific tests could, therefore, de-
pend on the objective of the analysis.
For 11 patients, multiple isolates from each patient 
were studied. The results of PRA-rpoB, PRA-16S and 
gyrB sequence analysis were consistent for all of the iso-
lates from the same patient, confirming the stability of 
the three developed tests. 
The PRA-rpoB test proved to be an efficient tool for 
the differentiation of the epidemic strain. The PRA-16S 
and the gyrB sequence analyses were shown to be use-
ful as additional tests. The rapid tests developed here 
can be performed in one day and the interpretation is 
straightforward for both the PRA tests (i.e., the presence 
or absence of digestion) and sequence analysis (i.e., the 
detection of one SNP). In contrast, PFGE requires ap-
proximately two weeks for completion, including the 
necessary culture period. Moreover, PFGE requires 
technical training, expensive equipment and software 
for analysis if a large number of isolates are assayed. The 
PRA-rpoB test can be performed in a shorter amount 
of time than PFGE and is easily executed, especially 
in laboratories that already use the PRA-hsp65 test for 
mycobacteria identification. The developed tests could 
be implemented for the epidemiological surveillance for 
the epidemic strain among surgical patient isolates that 
show the M. abscessus type 2 PRA-hsp65 pattern.
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Twelve conserved DNA regions studied
Isolates
5’ region of 
16S rDNA  
(448 bp)
23S rDNA  
(3,112 bp)
ITS  
(216 bp)
gyrA  
(549 bp)
hsp65  
(401 bp)
argH  
(533 bp)
cya  
(513 bp)
glpK  
(554 bp)
gnd  
(494 bp)
pgm  
(559 bp)
pta  
(673 bp)
purH  
(598 bp)
INCQS 00594 GU143891a GU143886 EU117206 GU131159 EU117205 JQ582469 JQ582470 JQ582577 JQ582471 JQ582592 JQ582600 JQ582608
Mycobacterium bolletii AY859681 GU143888.2 AM421291 GU131161 EU266576 FJ609780 FJ609784 FJ609781 FJ609783 HM371394 HM371395 HM371396
Mycobacterium massiliense AY593980 GU143887 AM421292 GU131160 EU266578 FJ609785 FJ609789 FJ609786 FJ609788 HM371391 HM371392 HM371393
B 67b - - - JQ582585 EU220417 - - JQ582578 - JQ582593 JQ582601 JQ582609
IAL 002c - - - JQ582586 - - - JQ582579 - JQ582594 JQ582602 JQ582610
IAL 014c - - - JQ582587 - - - JQ582580 - JQ582595 JQ582603 JQ582611
IAL 028c - - - JQ582588 - - - JQ582581 - JQ582596 JQ582604 JQ582612
P7d FJ590460 - - JQ582589 FJ536241 - - JQ582582 - JQ582597 JQ582605 JQ582613
P13 d FJ590466 - - JQ582590 FJ536247 - - JQ582583 - JQ582598 JQ582606 JQ582614
P53 d - - - JQ582591 - - - JQ582584 - JQ582599 JQ582607 JQ582615
P3 d - - - - FJ536237 - - - - - - -
P4 d - - - - FJ536238 - - - - - - -
P5 d - - - - FJ536239 - - - - - - -
P6 d FJ590459 - - - FJ536240 - - - - - - -
P8 d FJ590461 - - - FJ536242 - - - - - - -
P9 d FJ590462 - - - FJ536243 - - - - - - -
P10 d FJ590463 - - - FJ536244 - - - - - - -
P11 d FJ590464 - - - FJ536245 - - - - - - -
P12 d FJ590465 - - - FJ536246 - - - - - - -
P14 d FJ590467 - - - FJ536248 - - - - - - -
P15 d FJ590468 - - - FJ536249 - - - - - - -
B66b - - - - EU220418 - - - - - - -
B62b - - - - EU220419 - - - - - - -
B60b - - - - EU220420 - - - - - - -
sequences were aligned using CLUSTALW Multiple Alignment program (Thompson et al. 1994) included in BioEdit package version 7.0.5.3 (Hall 1999) for identification of single 
nucleotide polymorphisms (SNPs) present exclusively in INCQS 00594. Sizes of the analyzed fragments are in parenthesis. Exclusive SNPs of INCQS 00594 were not found in 23S 
rDNA, argH, cya and gnd and the internal transcribed sequence (ITS) region after alignment with two type strains. Alignment of the 5’ region of 16S rDNA and hsp65 sequences of 
INCQS 00594 and sequences available in GenBank has not evidenced exclusive SNPs for discrimination of the epidemic strain. glpK and pta could represent other targets to differenti-
ate the epidemic strain. a: GenBank accession; b: Viana-Niero et al. (2008); c: Matsumoto et al. (2011); d: da Costa et al. (2009); -: not analyzed.
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Primers used for polymerase chain reaction and sequencing of conserved DNA regions
Genes Primers Sequences 5’-3’
Temperature  
(ºC) References
23S rDNA Sp1 ACCTCCTTTCTAAGGAGCACC 64 Roth et al. (2000)
23S-1R CCCAAAGCCTATATATTCAGC 60 This paper
23S-2F AGCCTCGGGGAGCTGCCAACC 72
23S-2R GAGGCTTTGACGGATTGTAGG 64
23S-3F ACTCTCTAGTGACCGATAGCG 64
23S-3R AGTTTGGCTGACGTCAGTAAC 62
23S-4F ATTTAGGTGCAGCGTCGCGTG 66
23S-4R AAGTTTCTCACTTGCCTGTCG 62
23S-5F AGGGGAGCGTCCTGCACCCAG 72
23S-5R CGAAGTTACGGGGGTATTTTG 62
23S-6F TATGCTGCCAAGAAAAGCCTC 62
23S-6R TGTCCCTGGACCGGATATACG 66
23S-7F TGTGAAGCAGGCACGCCAGTG 68
23S-7R GTCCCGGTCCTCTCGTACTAG 68
23S-8R GTGGAGTGTGGTCGTCAAATG 62
gyrA GyrA-F GCCGTCGACCGCATCGAACCG 72 This paper
GyrA-R GTTGTCCAACGCCCAGTAGAC 66
argH ARGHF GACGAGGGCGACAGCTTC 60 Macheras et al. (2009)
ARGHSR1 GTGCGCGAGCAGATGATG 58
cya ACF GTGAAGCGGGCCAAGAAG 58 Macheras et al. (2009)
ACSR1 AACTGGGAGGCCAGGAGC 60
glpK GLPKSF1 AATCTCACCGGCGGTGTC 58 Macheras et al. (2009)
GLPKSFR2 GGACAGACCCACGATGGC 60
gnd GNDF GTGACGTCGGAGTGGTTGG 62 Macheras et al. (2009)
GNDSR1 CTTCGCCTCAGGTCAGCTC 62
pgm PGMSF1 CCATTTGAACCCGACCGG 58 Macheras et al. (2011)
PGMSR2 GTGCCAACGAGATCCTGCG 62
pta PTASF1 GATCGGGCGTCATGCCCT 60 Macheras et al. (2011)
PTASR2 ACGAGGCACTGCTCTCCC 60
purH PURHSF1 CGGAGGCTTCACCCTGGA 60 Macheras et al. (2011)
PURHSR2 CAGGCCACCGCTGATCTG 60
